Clindamycin phosphate 1.2% / Adapalene 0.15% / Benzoyl peroxide 3.1% Therapeutic Cheat Sheet
Cabtreo triple combination acne treatmentCabtreo is the first FDA-approved fixed-dose triple-combination topical treatment for acne vulgaris, pairing a lincosamide antibiotic (clindamycin), a synthetic retinoid (adapalene), and a keratolytic oxidizing agent (benzoyl peroxide) into a single once-daily gel. This formulation targets several pillars of acne pathogenesis simultaneously: cutaneous C. acnes proliferation, abnormal keratinizatio …
Cabtreo triple combination acne treatment
H1-Antihistamines Therapeutic Cheat Sheet | Part 1
Clinical presentation of chronic spontaneous urticaria on patient skin, showing erythematous wheals and hives, illustrating the primary dermatologic indication for H1-antihistamine therapy.Antihistamines, particularly second-generation histamine H1-receptor antagonists, are widely used in dermatology due to their antihistaminic activity and favorable safety profile characterized by minimal sedation compared with first-generation agents. They primarily act as peripheral H1-receptor antagonists, reducing histamine-mediated effects such as vasodilation, increased vascular permeability, …
Clinical presentation of chronic spontaneous urticaria on patient skin, showing erythematous wheals and hives, illustrating the primary dermatologic indication for H1-antihistamine therapy.
Bimatoprost Therapeutic Cheat Sheet
BimatoprostBimatoprost is a prostaglandin analog originally developed for glaucoma that has become an important tool in dermatology for the treatment of eyelash and eyebrow hypotrichosis. By prolonging the anagen phase of hair growth, bimatoprost enhances lash length, thickness, and pigmentation. We continue our Therapeutic Cheat Sheet series with a closer look at bimatoprost. Bimatoprost Therapeutic Cheat …
Bimatoprost
Topical Tacrolimus/Pimecrolimus Therapeutic Cheat Sheet
Topical Tacrolimus/Pimecrolimu Therapeutic Cheat SheetTacrolimus and Pimecrolimus are both calcineurin inhibitors FDA-approved for atopic dermatitis. However, their topical use offers steroid-sparing benefits for a wide variety of other inflammatory dermatologic conditions. Tacrolimus was discovered in 1984 from the soil bacterium Streptomyces tsukubaensis and was originally FDA approved in 1994 as a systemic immunosuppressant for organ transplanta …
Topical Tacrolimus/Pimecrolimu Therapeutic Cheat Sheet
Sodium Sulfacetamide-Sulfur Therapeutic Cheat Sheet
Sodium Sulfacetamide-Sulfur cheat sheetSulfur–sulfacetamide is a long-standing topical therapy in dermatology valued for its combined antimicrobial, anti-inflammatory, and keratolytic effects. It is commonly used for several conditions including acne vulgaris, papulopustular rosacea, and seborrheic dermatitis. Although newer targeted therapies are often preferred for rosacea, sulfur–sulfacetamide remains a practical option, especia …
Sodium Sulfacetamide-Sulfur cheat sheet